This study is designed to evaluate safety and efficacy of long-term exposure of KHK4827 in
subjects with moderate to severe plaque psoriasis who have completed the preceding Study
4827-002.
Phase:
Phase 3
Details
Lead Sponsor:
Kyowa Hakko Kirin Company, Limited Kyowa Kirin Co., Ltd.